Pfizer Agrees to Pay $44M to Settle Lawsuit Over Claims That Its Smoking‑Cessation Drug Chantix Contained an Undisclosed Nitrosamine

People who purchased Chantix during a six-year period could be eligible to receive money from a $44 million class action settlement over allegations that the smoking-cessation drug contained an undisclosed nitrosamine, a substance that can cause cancer.

Pfizer has agreed to pay $44 million to settle a lawsuit, although the company denies the allegations and maintains that it did nothing wrong. Also, the court has not sided with Pfizer or the plaintiffs.

Read more at USA Today